Effect of Carbon

Introduction
Carbon monoxide (CO), a gas, which is highly toxic to humans and animals when encountered in higher concentrations, binds rapidly to hemoglobin (Hb), leading to the stable formation of carboxyhemoglobin (COHb) [1] . As a result of CO binding to Hb both O 2 binding at high and O 2 release at low O 2 partial pressure are impaired [1] leading to a reduced oxygen carrying capacity of blood after CO inhalation [2] .
Besides its toxic effects at high concentrations, CO is a gaseous transmitter molecule [3] . In mammalian cells CO is generated by the enzyme heme-oxygenase [4] . CO participates in the regulation of a wide variety of cellular functions [5] [6] [7] [8] [9] and contributes to the regulation of cell death [10] [11] [12] [13] [14] [15] . CO may elicit both vasodilation and vasoconstriction [16, 17] . In addition, CO fosters coagulation and attenuates fibrinolysis in vitro and in vivo [18, 19] . CO can be released in an organism by the tricarbonyl-dichlororuthenium (II) dimer (CORM-2) [6] . CO-releasing molecules have been suggested as therapeutic option in various pathologies, but the risks of treatment with those molecules have been insufficiently addressed [6, 20] .
CO interferes with the function of cytochromes [21] [22] [23] . The cytochrome P450 enzyme 25-hydroxyvitamin D 3 1-alpha-hydroxylase accomplishes formation of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) from its inactive precursor (25-hydroxyvitamin D 3 ) [24] . The enzyme 25-hydroxyvitamin D 3 1-alpha-hydroxylase is encoded by the Cyp27b1 gene [24] . 1,25(OH) 2 D 3 is inactivated by 1,25-dihydroxyvitamin D 3 24-hydroxylase, an enzyme encoded by the Cyp24a1 gene [25] . 1,25(OH) 2 D 3 is a powerful regulator of CaHPO 4 metabolism and lack of 1,25(OH) 2 D 3 leads to rickets and osteomalacia [26] . Reduced levels of 1,25(OH) 2 D 3 are further associated with the onset and progression of various diseases such as respiratory infections, cardiovascular disease and cancer [27] [28] [29] [30] . 1,25(OH) 2 D 3 formation is inhibited by joint action of klotho and FGF23, proteins regulating phosphate homeostasis and implicated in various disorders including arteriosclerosis, cancer metastasis, and chronic kidney disease [31] [32] [33] . Furthermore, heme-oxygenase-1 is involved in bone metabolism and inflammation [34, 35] .
The present study explored, whether the CO donor tricarbonyl-dichlororuthenium (II) dimer (CORM-2) influences vitamin D 3 metabolism [6, 14] . To this end, vitamin D metabolism was investigated after CORM-2 injection into mice.
Materials and Methods
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities. Male and female BALB/c mice had free access to food (ssniff Spezialdiäten, Soest, Germany) containing 7000 mg/kg phosphorus and to tap drinking water ad libitum. Where indicated, the CO-releasing molecule tricarbonyldichlororuthenium (II) dimer (CORM-2, Sigma Aldrich, Taufkirchen, Germany), solubilized in dimethyl sulfoxide (DMSO, Sigma Aldrich), was injected intravenously (20 mg/kg body weight). Control mice were injected with vehicle (10% DMSO in saline solution).
To determine excretion of phosphate, the mice were placed individually in metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24-hour urine collection [36, 37] . They were allowed a 2-day habituation period. Subsequently, 24-hour collection of urine was performed. To assure quantitative urine collection, metabolic cages were siliconized, and urine was collected under water-saturated oil [38] . The urinary phosphate concentration was determined colorimetrically utilizing a commercial diagnostic kit (Roche Diagnostics, Mannheim, Germany) [39] .
To obtain blood specimens, mice were lightly anaesthetized with isoflurane (Abott, WiesbadenDelkenheim, Germany) and about 50 -200 µl of blood was withdrawn into heparinized capillaries by puncturing the retro-orbital plexus [40] . The plasma concentrations of phosphate and Ca 2+ were measured by a photometric method (FUJI FDC 3500i, Sysmex, Norsted, Germany). The creatinine concentrations in plasma were measured using a commercial enzymatic kit (creatinine PAP, Labor & Technik, Berlin, Germany, based on the creatininase method). An EIA kit was employed to determine plasma concentrations of 1,25(OH) 2 D 3 (IDS, Boldon, UK). Plasma FGF23 (C-Term) concentrations were determined utilizing a commercial ELISA Kit (Immutopics, San Clemente, USA) [41] . After 24 hours of CORM-2 treatment, mice were anesthetized with isoflurane and sacrificed by cervical dislocation. The kidneys were removed and immediately snap frozen in liquid nitrogen [42] . To determine protein expression by western blotting, kidneys were lysed with ice-cold lysis buffer (54.6 mM HEPES; 2.69 mM Na4P2O7; 360 mM NaCl; 10% [vol/vol] Glycerol; 1% [vol/vol] NP40) containing phosphatase and protease inhibitors (Complete mini, Roche, Mannheim, Germany). Homogenates were clarified by centrifugation at 12000 rpm for 20 min [43] . Total protein was separated by SDS-PAGE (8% Tris-Glycine), transferred to nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany), blocked for 1 h in blocking buffer (5% fat-free milk in Tris-buffered saline (TBS) containing 0.1% Tween (TBS-T)),and incubated overnight with an anti-klotho antibody (1:1000 in 5% fat-free milk in TBS-T, KM2076 (Rat), kindly provided by Kyowa Hakko Kirin Co. Ltd, Japan). After incubation with an anti-rat secondary antibody (1:2000 in 5% fat-free milk in TBS-T, Cell Signaling), the bands were visualized with enhanced chemiluminescence according to the manufacturer's instructions. Homogenates were also probed with a primary Gapdh antibody (1:2000 in 5% BSA in TBS-T, Cell Signaling) as a loading control. Densitometric analysis of klotho and Gapdh was performed using Quantity One software (Bio-Rad Laboratories, München, Germany).
Rat osteosarcoma UMR106 cells were routinely cultured in Dulbecco's Modified Eagle Medium (DMEM) containing 4,5 g/l glucose (PAA Laboratories, Cölbe, Germany), supplemented with 2 mM L-glutamine (PAA Laboratories, Cölbe, Germany), 10% fetal bovine serum FBS (Gibco, Life Technologies, Darmstadt, Germany), 100 U/ml penicillin and 100 µg/ml streptomycin (Gibco, Life Technologies, Darmstadt, Germany). Cells were treated for 24 hours with 20 µM CORM-2 (Sigma-Aldrich, Taufkirchen, Germany) dissolved in DMSO (Sigma-Aldrich, Taufkirchen, Germany). Equal amounts of vehicle were used as control.
Total RNA was isolated from kidney samples and from UMR106 cells by using Trifast Reagent (Peqlab, Erlangen, Germany) according to the manufacturer's instructions [44] . Reverse transcription of 2µg RNA was performed using oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen, Darmstadt, Germany) and SuperScriptIII Reverse Transcriptase (Invitrogen, Darmstadt, Germany). cDNA samples were treated with RNaseH (Invitrogen, Darmstadt, Germany). Quantitative real-time PCR was performed with the iCycler iQ TM Real-Time PCR Detection System (Bio-Rad Laboratories, München, Germany) and iQ TM Sybr Green Supermix (Bio-Rad Laboratories, München, Germany) according to the manufacturer's instructions. The following mouse primers were used (5'→3' orientation) for quantitative RT-PCR measurements:
Cyp24a1 fw: GTGAAGCGTGCGCCAAAAG; Cyp24a1 rev: CTCACCGTCGGTCATCAGC; Cyp27b1 fw: CAGTTTACGTTGCCGACCCTA; Cyp27b1 rev: GGACAGTGACTTTCTTGTCGC; Gapdh fw: AGGTCGGTGTGAACGGATTTG; Gapdh rev: TGTAGACCATGTAGTTGAGGTCA; Klotho fw: CCCTGTGACTTTGCTTGGG; Klotho rev: CCCACAGATAGACATTCGGGT. The following rat primers were used (5'→3' orientation) for quantitative RT-PCR measurements:
Fgf23 fw: TTGGATCGTATCACTTCAGC; Fgf23 rev: TGCTTCGGTGACAGGTAG; Gapdh fw: GGCAAGTTCAATGGCACAGT; Gapdh rev: TGGTGAAGACGCCAGTAGACTC.
The specificity of the PCR products was confirmed by analysis of the melting curves and in addition by agarose gel electrophoresis. All PCRs were performed in duplicate, and mRNA fold changes were calculated by the 2 -ΔΔCt method using Gapdh as internal reference. Data are expressed as arithmetic means ± SEM, and n represents the number of independent experiments. Statistical analysis was made using unpaired Student t-test or Mann-Whitney test. Only differences with p < 0.05 were considered statistically significant.
Results
To investigate the effects of the tricarbonyl-dichlororuthenium (II) dimer (CORM-2) on vitamin D metabolism, the CO-releasing molecule CORM-2 was administered to mice by intravenous injection. For comparison, equal amounts of DMSO vehicle was injected into control mice. CORM-2 releases a controlled amount of CO in biological systems [6] . CORM-2 treatment of mice for 24 hours led to a statistically significant decrease of plasma 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) concentration as compared to the control treated mice (Fig. 1) . The decrease of plasma 1,25(OH) 2 D 3 concentrations following CORM-2 treatment was accompanied by a statistically significant decrease of renal transcript levels of Cyp27b1, the gene encoding 25-hydroxyvitamin D 3 1-alpha-hydroxylase, a cytochrome P450-dependent enzyme producing 1,25(OH) 2 D 3 ( Fig.2A) . Transcript levels of Cyp24a1 encoding the 1,25(OH) 2 D 3 inactivating 1,25-dihydroxyvitamin D 3 24-hydroxylase tended to increase following CORM-2 treatment, an effect, however, not reaching statistical significance (Fig.  2B) . Despite reduced 1,25(OH) 2 D 3 levels, no significant difference was observed in the plasma Ca 2+ concentrations between the control treated mice (8.90 ± 0.17 mg/dl, n = 12) and CORM-2 treated mice (9.09 ± 0.13 mg/dl, n = 12). Similarly, plasma phosphate concentrations were not significantly different between control treated mice (6.75± 0.36 mg/dl, n = 12) and CORM-2 treated mice (6.76 ± 0.37 mg/dl, n = 12). Furthermore, the urinary phosphate excretion was not significantly different between control treated mice (2.34 ± 0.36 µmol/24h/[g]BW, n = 12) and CORM-2 treated mice (2.65 ± 0.42 µmol/24h/[g]BW, n = 12). In addition, 12 hours after the injection of CORM-2, plasma creatinine concentrations were not significantly different between CORM-2 treated mice (0.383 ± 0.040 mg/dl, n = 5) and control treated mice (0.300 ± 0.038 mg/dl, n = 5).
CORM-2 injection was, however, followed by an increase of plasma FGF23 concentration. As shown in Fig. 3A , the plasma FGF23 (C-Term) levels were significantly higher in mice receiving CORM-2 treatment than in control treated mice. To investigate, whether CORM-2 could directly affect FGF23 production, rat osteosarcoma UMR106 cells were treated for 24 hours with DMSO as control or with 20 µM CORM-2 (Fig. 3B) . As a result, CORM-2 induced a statistically significant increase in Fgf23 mRNA expression in UMR106 cells as compared to the vehicle treated UMR106 cells.
Renal Klotho mRNA levels determined by quantitative RT-PCR, were significantly lower in mice following CORM-2 treatment than in control treated mice (Fig. 4A) . According to western blotting, the renal abundance of klotho protein was again significantly lower in CORM-2 treated mice than in control treated mice (Fig. 4B,C) .
Discussion
The present study discloses that the CO donor tricarbonyl-dichlororuthenium (II) dimer (CORM-2) decreases renal transcript levels of Cyp27b1, the gene encoding the 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 FGF23 is mainly produced and released by osteoblasts/osteocytes [45] . The upregulation of FGF23 plasma levels and mRNA expression in UMR106 cells may thus point to a direct effect of CORM-2 on FGF23 release from bone. We cannot rule out effects of CORM-2 indirectly modifying FGF23 release. As FGF23 release is stimulated by 1,25(OH) 2 D 3 [45] , the upregulation of FGF23 release cannot be explained by the decline of 1,25(OH) 2 D 3 plasma levels. As FGF23 downregulates 1-alpha-hydroxylase [45] , the increased FGF23 plama levels could, however, contribute to or even account for the decreased 1,25(OH) 2 D 3 formation following CORM-2 treatment. FGF23 modifies 1,25(OH) 2 D 3 plasma levels by inhibiting formation rather than stimulating 1,25(OH) 2 D 3 degradation [46] . The inhibitory effect on 1,25(OH) 2 D 3 formation could further be due to down-regulation of Cyp27b1 (Fig. 2) and/or binding of CO to cytochrome P450 with subsequent impairment of 25-hydroxyvitamin D 3 1-alpha-hydroxylase activity [24] . The downregulation of klotho would, however, be expected to attenuate the effect of FGF23 on 25-hydroxyvitamin D 3 1-alpha-hydroxylase activity [45, 47] .
CO increases cellular oxygen consumption, reduces mitochondrial respiratory capacity and increases VEGF production via HIF-1α, which could possibly contribute to the regulation of FGF23 by CORM-2 [48, 49] . Along those lines production of FGF23, Cyp24a1 and Cyp27b1 expression as well as 1,25(OH) 2 vitamin D 3 plasma levels are modified by iron deficiency, an effect associated with tissue hypoxia [50, 51] .
As 1,25(OH) 2 D 3 stimulates the expression of klotho [45] , the decrease of 1,25(OH) 2 D 3 formation could contribute to or even account for the decrease of klotho expression following CORM-2 treatment. The regulation of Klotho mRNA expression is vitamin D 3 receptormediated, and vitamin D 3 response elements (VDREs) in both mouse and human klotho genes have been identified [52] . Beyond that, a direct toxic effect of the ruthenium based carrier molecule of CORM-2 on the kidney cannot be ruled out [20] . CORM-2 did, however, not significantly affect plasma creatinine, calcium and phosphate concentrations or urinary phosphate excretion.
The influence of CORM-2 described here may contribute to the known effects of CORM-2. Several vasculoprotective effects of lower dosages of CORM-2 have been described and low dosages of CO are associated with nephroprotection [53] . However, increased endogenous carbon monoxide production may be involved in diabetes induced endothelial dysfunction [54] . Similarly, klotho is decreased in the db/db, streptozotocin diabetes models and human diabetic nephropathy [55] [56] [57] . Heme oxygenase derived endogenous CO promotes endothelial dysfunction in hypertensive rats, and high levels of CO could impair nitric oxide release [58] . Blockage of the nitric oxide synthase also leads to reduced klotho expression [59] .
Biological effects of 1,25(OH) 2 D 3 are mainly mediated by activation of the vitamin D 3 receptor (VDR) [60, 61] . Low 1,25-dihydroxyvitamin D 3 levels may lead to demineralization of bone [26] and in addition play a role in the development and progression of multiple chronic diseases such as cancer, infections, and cardiovascular disorders [27] [28] [29] [30] .
The present observations may hint at effects of smoking, which leads to massive formation of CO [62, 63] . CO binds rapidly to hemoglobin (Hb), leading to the stable formation of carboxyhemoglobin (COHb) [2] . Similar to 1,25(OH) 2 D 3 formation after CORM-2 treatment, smoking is associated with reduced vitamin D 3 levels without changes in serum calcium [64] . Furthermore, history of tobacco smoking is associated with elevated FGF23 levels in CKD patients [65] . Tobacco smoke plays a decisive role in the pathogenesis of lung cancer [66] , chronic obstructive pulmonary disease (COPD) [66] and cardiovascular disease [67] . The underlying mechanisms are incompletely understood [68] , but may, at least in theory, involve altered action of 1,25(OH) 2 D 3 , klotho or FGF23. Both, COPD and smoking, are associated with an increased carbon monoxide load and risk of vitamin D 3 deficiency [69, 70] . 1,25(OH) 2 D 3 may be a potent regulator of several signaling pathways, which are involved in oncogenic transformation [25, 61, 71] . Secreted klotho functions as a humoral factor and regulates the activity of multiple growth factors, including insulin/insulin-like growth factor-1 (IGF-1) [72] , Wnt [73] , and TGF-ß1 [74] . Soluble klotho has been identified as a potent inhibitor of the insulin/IGF-1 pathways in cancer cells [75, 76] . Klotho inhibits lung cancer cell growth and klotho expression is a predictor of a favourable outcome in lung cancer patients [77, 78] . Future studies will be required to define the role of decreased 1,25(OH) 2 D 3 and klotho formation in the untoward effects of CO.
Conclusion
CORM-2 leads to a decrease of 25-hydroxyvitamin D 3 1-alpha-hydroxylase expression and activity resulting in decreased formation of 1,25(OH) 2 D 3 and klotho expression. Moreover, CORM-2 increases the formation of FGF23. The observations disclose an impact of CO-releasing molecules on mineral metabolism.
